Penserra Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-35,162
Closed -$1.3M 1059
2025
Q1
$1.3M Buy
+35,162
New +$1.25M 0.02% 366
2022
Q2
Sell
-15,705
Closed -$356K 1422
2022
Q1
$356K Buy
+15,705
New +$307K 0.01% 583
2020
Q4
Sell
-2,642
Closed -$64K 1049
2020
Q3
$64K Buy
+2,642
New +$61.7K ﹤0.01% 606
2019
Q1
Sell
-5,535
Closed -$108K 740
2018
Q4
$108K Buy
+5,535
New +$98.7K 0.01% 362
2018
Q1
Sell
-914
Closed -$27K 500
2017
Q4
$27K Buy
+914
New +$24.3K ﹤0.01% 288

Other funds holding EXEL

Penserra Capital Management's EXEL Position: Q2 2025 in Review

Penserra Capital Management sold out of Exelixis (EXEL) in Q2 2025, closing a stake of 35,162 shares — an estimated $1.3M sold.

Penserra Capital Management first reported a position in EXEL in Q4 2017 and held it in 5 quarters. The position peaked at $1.3M in Q1 2025. 633 funds tracked by Wall St. Rank hold EXEL as of Q2 2025.

  • Penserra Capital Management reported no remaining Exelixis position as of Q2 2025 after selling out during the quarter.
  • Penserra Capital Management sold 35,162 Exelixis shares in Q2 2025, an estimated $1.3M.
  • Penserra Capital Management first reported a position in Exelixis in Q4 2017 and held it in 5 quarters.
  • Penserra Capital Management's Exelixis position peaked at $1.3M in Q1 2025.
  • 633 funds tracked by Wall St. Rank held Exelixis as of Q2 2025.

Based on Penserra Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.